Related Experiment Videos
Prolonged severe pancytopenia preceding the cutaneous lesions of juvenile xanthogranuloma
Takuya Hara1, Shouichi Ohga, Sagano Hattori
1Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Maidashi, Fukuoka, Japan.
Insights
Juvenile xanthogranuloma (JXG) can present with pancytopenia mimicking leukemia in infants. Early diagnosis via skin biopsy and bone marrow examination is crucial for managing this rare condition.
Area of Science:
- Pediatric Hematology
- Dermatopathology
- Oncology
Background:
- Juvenile xanthogranuloma (JXG) is a rare, benign histiocytic disorder typically affecting infants and children.
- While often presenting with skin lesions, visceral involvement can occur, posing diagnostic challenges.
Observation:
- A 2-month-old infant presented with progressive pancytopenia, fever, anemia, and hepatosplenomegaly, mimicking hemophagocytic lymphohistiocytosis (HLH) or juvenile myelomonocytic leukemia (JMML).
- Skin lesions developed, and an 8-month-old infant's elbow papule biopsy confirmed JXG.
- Bone marrow examination revealed foamy cells and hemophagocytosis by histiocytes.
Findings:
- The case highlights a rare presentation of JXG with significant bone marrow failure.
- Histopathological examination of bone marrow confirmed the presence of characteristic foamy cells and hemophagocytosis.
Implications:
- Multisystemic JXG with bone marrow failure in infancy requires consideration as an aggressive entity, despite JXG's generally benign nature.
- Prompt diagnosis and appropriate therapeutic interventions, such as etoposide and vinblastine plus prednisolone, can lead to disease improvement.
Abstract:
We report a case of juvenile xanthogranuloma (JXG) having progressive pancytopenia for 6 months until the proliferating skin lesions. A 2-month-old infant presented recurrent fever, anemia, and hepatosplenomegaly mimicking hemophagocytic lymphohistiocytosis (HLH) or juvenile myelomonocytic leukemia (JMML). At 8 months of age, the biopsy of a growing papule on the elbow made the diagnosis. Bone marrow (BM) specimens showed clustering foamy cells including hemophagocytosis by histiocytes. Treatment with etoposide followed by vinblastine plus prednisolone (PSL) therapy improved the disease. Although JXG is a benign non-Langerhans cell histiocytosis, the multisystem-visceral form should be considered as a potential aggressive disease when associated with BM failure in early infancy.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...